Phase 2 Catecholaminergic Polymorphic Ventricular Tachycardia Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase 2 Study of CRD-4730 in CPVT
Catecholaminergic Polymorphic Ventricular Tachycardia
Cardurion Pharmaceuticals, Inc.12 enrolled9 locationsNCT06658899
Recruiting
Phase 2
Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Catecholaminergic Polymorphic Ventricular Tachycardia
Agiana Pharmaceuticals10 enrolled1 locationNCT07263139